Assisted reproductive technology and ovarian cancer

被引:1
|
作者
Devesa, M. [1 ]
Barri, P. N. [1 ]
Coroleu, B. [1 ]
机构
[1] Inst Univ Dexeus, Serv Reprod Med, Dept Obstet Gynecol & Reprod, Barcelona 08028, Spain
关键词
Ovarian neoplasms; Infertility; Fertility agents; Ovulation induction; IN-VITRO FERTILIZATION; ORAL-CONTRACEPTIVE USE; TERM-FOLLOW-UP; FERTILITY DRUGS; OVULATION INDUCTION; INFERTILE WOMEN; RISK; STIMULATION; COHORT; BREAST;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovarian cancer has the highest mortality among all gynaecological cancers, being multiparity and oral contraceptive use the most important protective factors. According to both the "incessant ovulation" and "increased gonadotrophin" theories, fertility drugs might hive an association with the development of ovarian cancer, as has been reported by some studies. However, infertility and nulliparity may act as confounding factors and most studies regarding this issue are hampered by methodological limitations. It seems that female infertility may be associated with a modest increase in ovarian cancer risk in those patients who remain nulligravid despite long periods of unprotected intercourse. Globally, most studies are reassuring in not showing a link between the use of fertility drugs and an increased risk of ovarian cancer. Nonetheless, further research in well-designed studies is warranted.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 50 条
  • [1] OVARIAN-CANCER AND ASSISTED REPRODUCTIVE TECHNOLOGY
    LOPES, P
    MENSIER, A
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 51 (03): : 171 - 173
  • [3] Assisted reproductive technology (ART) treatment and risk of ovarian cancer
    Vassard, D.
    Glazer, C. H.
    Forman, J. Lyng
    Kamper-Jorgensen, M.
    Pinborg, A.
    Schmidt, L.
    HUMAN REPRODUCTION, 2018, 33 : 87 - 88
  • [4] Assisted reproductive technology and the incidence of ovarian cancer: A meta-analysis
    Kashyap, S
    Moher, D
    Fung, MFK
    Rosenwaks, Z
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 785 - 794
  • [5] Assessment of ovarian reserve in Assisted Reproductive Technology
    Shiguehara Yamakami, Lucas Yugo
    Alkimin, Rafaela
    Izzo, Carlos Roberto
    Serafini, Paulo
    Baracat, Edmund Chada
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2010, 14 (03): : 39 - 42
  • [6] Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging
    Tamura, Hiroshi
    Jozaki, Mai
    Tanabe, Manabu
    Shirafuta, Yuichiro
    Mihara, Yumiko
    Shinagawa, Masahiro
    Tamura, Isao
    Maekawa, Ryo
    Sato, Shun
    Taketani, Toshiaki
    Takasaki, Akihisa
    Reiter, Russel J.
    Sugino, Norihiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [7] Ovarian stimulation protocols in assisted reproductive technology: an update
    Howles, Colin M.
    Ezcurra, Diego
    Homburg, Roy
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (03) : 319 - 330
  • [8] Effect of repeated assisted reproductive technology on ovarian response
    Kelly, SM
    Buckett, WM
    Tan, SL
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2003, 15 (03) : 219 - 224
  • [9] CONTROLLED OVARIAN HYPERSTIMULATION - AN ADJUNCT TO ASSISTED REPRODUCTIVE TECHNOLOGY
    MASCARENHAS, L
    KHASTGIR, G
    DAVIES, WAR
    LEE, S
    FERTILITY AND STERILITY, 1994, 61 (06) : 1158 - 1160
  • [10] Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology
    Spaan, Mandy
    van den Belt-dusebout, Alexandra W.
    Lambalk, Cornelis B.
    van Boven, Hester H.
    Schats, Roel
    Kortman, Marian
    Broekmans, Frank J. M.
    Laven, Joop S. E.
    van Santbrink, Evert J. P.
    Braat, Didi D. M.
    van der Westerlaken, Lucette A. J.
    Cohlen, Ben J.
    Cantineau, Astrid E. P.
    Smeenk, Jesper M. J.
    van Rumste, Minouche M.
    Goddijn, Mariette
    van Golde, Ron J. T.
    Meeuwissen, Paul A. M.
    Hamilton, Carl J. C. M.
    Ouwens, Gabriele M.
    Gerritsma, Miranda A.
    Schaapveld, Michael
    Burger, Curt W.
    van Leeuwen, Flora E.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (07) : 408 - 410